Tarsus prices USD 125 million PIPE at USD 56 per share

Reuters2026/08/06 11:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tarsus Pharmaceuticals priced an oversubscribed $125 million PIPE, selling 2,098,519 common shares at USD 56 per share.
The deal also includes pre-funded warrants for 133,625 shares at USD 56 each, with a USD 0.0001 exercise price.
Closing is expected on Aug. 7, 2026, subject to customary conditions.
Proceeds are earmarked for clinical development, commercial activities, and general corporate purposes.
Barclays is lead placement agent; BofA Securities, William Blair are co-placement agents.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tarsus prices USD 125 million PIPE at USD 56 per share

You may also like

Crypto prices